Replies

Dear Admin, I accidentally posted a date instead of the title for this article, which is:

Monkey Data Support Moderna COVID-19 Vaccine
— Prevents disease, perhaps transmission too in preclinical tests

If possible, could you update the title? I apologize for the error.

This is what she's complaining about. The Moderna test with monkeys was very successful, and the monkeys are fine. The angst about the issue doesn't make sense to me. It is what it is. Follow the link. It's a quick and easy read.

Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna
July 28, 2020 at 3:23 PM EDT

[Excerpt:]
"mRNA-1273 induced robust neutralizing antibodies and dose dependent increases in T cell responses

mRNA-1273 led to protection against SARS-CoV-2 infection in the lungs and nose of non-human primates

No evidence of vaccine-associated enhanced disease (VAERD) observed"

Also of interest in regards to the monkeys in the test (8 in the 100 µg group, 8 in the placebo group, don't know how many in the 10µg group),...

"Two doses of mRNA-1273 provided protection against lung inflammation following viral challenge with SARS-CoV-2 in non-human primates at both the 10 µg and 100 µg dose levels. In addition, both the 10 µg and 100 µg dose groups demonstrated protection against viral replication in the lungs, with the 100 µg dose also protecting against viral replication in the nose of the animals. Of note, none of the eight animals in the 100 µg group showed detectable viral replication in the nose compared to six out of eight in the placebo group on day 2.

'This important preclinical study shows that mRNA-1273 protected against a high dose SARS-CoV-2 infection in non-human primates and prevented pulmonary disease in all animals, further supporting the clinical advancement of mRNA-1273,' said Stephen Hoge, M.D., President at Moderna."

Moderna Announces Publication in The New England Journal of Medicine of Non-Human Primate Preclinical Viral Challenge Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna
July 28, 2020 at 3:23 PM EDT